Cerebral cavernous malformations: somatic mutations in vascular endothelial cells

Judith Gault1, Issam A Awad, Peter Recksiek

  • 1Department of Neurosurgery, University of Colorado, Denver, Aurora, Colorado, USA. Judith.Gault@UCDenver.edu

Neurosurgery
|July 4, 2009
PubMed
Abstract

Insights

Somatic KRIT1 mutations in cerebral cavernous malformations (CCMs) occur in vascular endothelial cells, supporting a "2-hit" mechanism. This finding highlights the importance of targeting these cells for future diagnostic methods.

Area of Science:

  • Genetics
  • Molecular Biology
  • Vascular Biology

Background:

  • Cerebral cavernous malformations (CCMs) are linked to germline mutations in specific genes.
  • A "2-hit" mechanism involving somatic and germline mutations in KRIT1 has been previously identified in CCM lesions.
  • Understanding the cellular origin of somatic mutations is crucial for CCM pathogenesis.

Purpose of the Study:

  • To investigate somatic, nonheritable mutations in additional CCM lesions.
  • To identify the specific cell types within CCM lesions harboring somatic mutations.
  • To further elucidate the "2-hit" mechanism in CCM development.

Main Methods:

  • Somatic mutations were screened in DNA from excised CCM lesions using polymerase chain reaction and cloning.
  • KRIT1 and PDCD10 coding regions were analyzed for mutations.
  • Laser capture microdissection isolated endothelial and nonendothelial cells for mutation analysis.

Main Results:

  • Somatic KRIT1 mutations were identified in the vascular endothelial cells of CCM lesions from two patients.
  • These somatic mutations, along with germline mutations, result in biallelic inactivation and protein truncation.
  • No conclusive somatic mutations were found in other lesions, potentially due to technical limitations or cell composition.

Conclusions:

  • The "2-hit" mechanism in CCMs involves somatic mutations occurring in vascular endothelial cells.
  • This cellular localization was observed in patients with both somatic and germline KRIT1 mutations.
  • Future diagnostic strategies for somatic mutations should prioritize vascular endothelial cells within pristine CCM caverns.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...